| [1] |
Rebuffat SA, Sidot E, Guzman C, et al. Adipose tissue derived-factors impaired pancreatic β-cell function in diabetes [J]. Biochimica et Biophysica Acta Molecular Basis of Disease, 2018, 1864(10): 3378-3387.
|
| [2] |
Yue T, Xu S, Huang LL, et al. Obesity and insulin resistance: Pathophysiology and treatment [J]. Drug Discovery Today, 2021, 11(01): 10-16..
|
| [3] |
Michailidou Z, Gomez-Salazar M, Alexaki VI. Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease [J]. Journal of Innate Immunity, 2022, 14(1): 4-30.
|
| [4] |
Yu LL, Li YH, Du CC, et al. Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases [J]. Mediators of Inflammation, 2019, 2019: 5271295.
|
| [5] |
Chung KJ, Nati M, Chavakis T, et al. Innate immune cells in the adipose tissue [J]. Reviews in endocrine & Metabolic Disorders, 2018, 19(4): 283-292.
|
| [6] |
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization [J]. Journal of Clinical Investigation, 2007, 117(1): 175-184.
|
| [7] |
Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas [J]. Journal of Clinical Investigation, 2012, 122(3): 787-795.
|
| [8] |
Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system [J]. Nature Reviews Endocrinology, 2016, 12(1): 15-28.
|
| [9] |
Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders [J]. Nature, 2017, 542(7640): 177-185.
|
| [10] |
Nussbaum JC, Van-Dyken SJ, Moltke J, et al. Type 2 innate lymphoid cells control eosinophil homeostasis [J]. Nature, 2013, 502(7470): 245-248.
|
| [11] |
Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase [J]. Nature Medicine, 2012, 18(9): 1407-1412.
|
| [12] |
Zatterale F, Longo M, Naderi J, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes [J]. Frontiers in Physiology, 2019, 10: 1607.
|
| [13] |
Wang Q, Wu HZ. T Cells in Adipose Tissue: Critical Players in Immunometabolism[J]. Frontiers in Immunology, 2018, 9: 2509.
|
| [14] |
Bapat SP, Myoung-Suh J, Fang S, et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance [J]. Nature, 2015, 528(7580): 137-141.
|
| [15] |
McLaughlin T, Liu LF, Lamendola C, et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014, 34(12): 2637-2643.
|
| [16] |
Gola A, Dorrington MG, Speranza E, et al. Commensal-driven immune zonation of the liver promotes host defence [J]. Nature, 2021, 589(7840): 131-136.
|
| [17] |
Liu X, Yu L, Hassan W, et al. The Duality of Kupffer Cell Responses in Liver Metabolic States [J]. Current Molecular Medicine, 2016, 16(9): 809-819.
|
| [18] |
Wan MJ, Han JW,, Ding Lili, et al. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis [J]. Frontiers in Medicine, 2021, 8: 604894.
|
| [19] |
Koyama Y, and Brenner DA. Liver inflammation and fibrosis [J]. Journal of Clinical Investigation, 2017, 127(1): 55-64.
|
| [20] |
Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease [J]. Trends in Endocrinology and Metabolism, 2021, 32(7): 500-514.
|
| [21] |
Ray I, Mahata SK, De RK. Obesity: An Immunometabolic Perspective [J]. Frontiers in Endocrinology, 2016, 7: 157.
|
| [22] |
Fink LN, Oberbach A, Costford SR, et al. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes [J]. Diabetologia, 2013, 56(7): 1623-1628.
|
| [23] |
Khan, IM, Perrard XY, Brunner G, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance [J]. International Journal of Obesity, 2015, 39(11): 1607-1618.
|
| [24] |
Citro A, Campo F, Dugnani E, et al. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies [J]. Frontiers in Endocrinology, 2020, 11: 606332.
|
| [25] |
Cosentino C, Regazzi R. Crosstalk between Macrophages and Pancreatic β-Cells in Islet Development, Homeostasis and Disease [J]. International Journal of Molecular Sciences, 2021, 22(4): 1765.
|
| [26] |
Böni-Schnetzler M, Meier DT. Islet inflammation in type 2 diabetes [J]. Seminars in Immunopathology, 2019, 41(4): 501-513.
|
| [27] |
Winer, DA, Luck H, Tsai S, et al. The Intestinal Immune System in Obesity and Insulin Resistance [J]. Cell Metabolism, 2016, 23(3): 413-426.
|
| [28] |
Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, et al. The Role of the Gut Microbiota in Bile Acid Metabolism [J]. Annals of Hepatology, 2017, 16 Suppl 1: S21-S26.
|
| [29] |
Torres-Fuentes C, Schellekens H, Dinan TG, et al. The microbiota-gut-brain axis in obesity [J]. The Lancet Gastroenterology & Hepatology, 2017, 2(10): 747-756.
|
| [30] |
Cox, AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota [J]. Lancet Diabetes & Endocrinology, 2015, 3(3): 207-215.
|
| [31] |
Moffa S, Mezza T, Cefalo CMA, et al. The Interplay between Immune System and Microbiota in Diabetes[J]. Mediators of Inflammation, 2019, 2019: 9367404.
|
| [32] |
Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta [J]. Science, 2001, 293(5535): 1673-1677.
|
| [33] |
Hawley, SA, Fullerton MD, Ross FA, et al. The ancient drug salicylate directly activates AMP-activated protein kinase [J]. Science, 2012, 336(6083): 918-922.
|
| [34] |
Ghanbari M, Momen Maragheh S, Aghazadeh A, et al. Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies [J]. International Immunopharmacology, 2021, 96: 107765.
|
| [35] |
Rissanen A, Howard CP, Botha J, et al. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial [J]. Diabetes Obesity & Metabolism, 2012, 14(12): 1088-1096.
|
| [36] |
Nanjan MJ, Mohammed M, Prashantha Kumar BR, et al. Thiazolidinediones as antidiabetic agents: A critical review [J]. Bioorganic Chemistry, 2018, 77: 548-567.
|
| [37] |
Yu SY, Cheng Y, Zhang LX, et al. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats [J]. Stem Cell Research & Therapy, 2019, 10(1): 333.
|
| [38] |
Moon KC, Suh HS, Kim KB, et al. Potential of Allogeneic Adipose-Derived Stem Cell-Hydrogel Complex for Treating Diabetic Foot Ulcers [J]. Diabetes, 2019, 68(4): 837-846.
|
| [39] |
Akbari M, Hassan-Zadeh V. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes [J]. Inflammopharmacology, 2020, 28(2): 345-362.
|
| [40] |
Zhao YS, Chen B, Shen J, et al. The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity [J]. Oxidative Medicine and Cellular Longevity, 2017, 2017: 1459497.
|
| [41] |
Das B, Das M, Kalita A, et al. The role of Wnt pathway in obesity induced inflammation and diabetes: a review [J]. Journal of Diabetes & Metabolic Disorders, 2021, 20(2): 1871-1882.
|